NVAX

NVAX

USD

Novavax Inc. Common Stock

$7.510-0.175 (-2.277%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$7.685

最高价

$7.860

最低价

$7.500

成交量

5.04M

公司基本面

市值

1.2B

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

6.00M

交易所

NMS

货币

USD

52周价格范围

最低价 $5.01当前价 $7.510最高价 $11.55

相关新闻

Analyst Upgrades

TD Cowen Maintains Hold on Novavax, Lowers Price Target to $7

TD Cowen analyst Brendan Smith maintains Novavax with a Hold and lowers the price target from $8 to $7.

查看更多
TD Cowen Maintains Hold on Novavax, Lowers Price Target to $7
PR Newswire

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the U.S. marketing authorization for its COVID-19 vaccine, Nuvaxovid™ to Sanofi, enabling...

查看更多
Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment
Analyst Upgrades

Cantor Fitzgerald Initiates Coverage On Novavax with Overweight Rating, Announces Price Target of $18

Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on Novavax with a Overweight rating and announces Price Target of $18.

查看更多
Cantor Fitzgerald Initiates Coverage On Novavax with Overweight Rating, Announces Price Target of $18
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Novavax, Raises Price Target to $11

HC Wainwright & Co. analyst Sean Lee maintains Novavax with a Buy and raises the price target from $10 to $11.

查看更多
HC Wainwright & Co. Maintains Buy on Novavax, Raises Price Target to $11
PR Newswire

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Novavax, Inc. (Nasdaq: NVAX) today announced that it has further executed against its planned transformation into a lean, agile operating model by...

查看更多
Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy